|
Miricorilant Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since July 2026
Pipeline
Phase 1: 1
Top Sponsors
- Corcept Therapeutics1
Indications
- Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis1
- Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)1
- Nonalcoholic Steatohepatitis (NASH)1
- Liver Disease1
- Non-alcoholic Fatty Liver Disease NAFLD1
San Antonio, Texas1 trial
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.